Last reviewed · How we verify
NCT02983240
Electrical Inhibition of Human Preterm Contractions
NA trial testing Electrical Uterine Pacemaker in Preterm Labor in 110 participants. Suspended.
21 January 2026
Quick facts
| Lead sponsor | e-Bio Corp |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 1 March 2017 |
| Primary completion | 21 January 2026 |
| Estimated completion | 21 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Electrical Uterine Pacemaker
Conditions studied
- Preterm Labor — all drugs for Preterm Labor →
- PreTerm Birth — all drugs for PreTerm Birth →
- Preterm Labor With Delivery Nos — all drugs for Preterm Labor With Delivery Nos →
Sponsor
e-Bio Corp
Who can join
Adults 18 to 50, female only, with Preterm Labor or PreTerm Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to explore a new method to stop preterm uterine contractions using an electrical device. The device, an "electrical pacemaker for the uterus," has been approved by the Food and Drug Administration (FDA) for clinical research in pregnant women. The purpose of this study is to evaluate the feasibility and safety of the device. The investigators hypothesize that human preterm uterine contractions can be safely and objectively inhibited with a weak electrical current provided by an electrical inhibition (EI)/uterine pacemaker device, and that this effect relates to the timing and length of EI exposure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02983240
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Labor
Currently open trials in the same condition.
- NCT07015203 — The Combined First Trimester Screening · recruiting
- NCT07263490 — PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · recruiting
- NCT06053697 — Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies? · active not recruiting
- NCT05698966 — Low Dose Antenatal Corticosteroids for Late Preterm Delivery · NA · recruiting
- NCT06074601 — MIRACLE of LIFE Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02983240 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by e-Bio Corp
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02983240.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing